Adamson Philip B. reported CVRX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002056191-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Feb 27, 2026

Published

Mar 16, 2026

Ingested by INSIDER

Nov 5, 04:11 UTC

Last re-read

Nov 5, 04:11 UTC

Extracted facts

Filer

Adamson Philip B.

Role

Chief Medical Officer

Transaction

Grant or awardAs filed: “A”

Asset

CVRx, Inc.

Ticker

CVRX

Shares

41.0K

Price per share

$0

Execution date (reported)

Feb 27, 2026

Owned after transaction

62.8K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

17

What this establishes

Adamson Philip B. filed this Form 4 reporting a grant or award of CVRX on Feb 27, 2026. It became public on Mar 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Medical Officer

Adamson Philip B.cik:0002056191

Issuer

CVRx, Inc.cik:0001235912

Revision history · 0

No field has changed since this record was first ingested.